bool(false) int(1) int(0) UEG - United European Gastroenterology

LONG-TERM SAFETY OF OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC) AND RELAPSING MULTIPLE SCLEROSIS (RMS) STUDIES

Silvio Danese  1     Douglas C. Wolf  2     OLGA ALEKSEEVA  3     Lorna Charles  4     Sonia Afsari     AnnKatrin Petersen     James K. Sheffield     Hongjuan Li     Diego Silva     Fred Lublin     Bruce A. C. Cree     Jeffrey Cohen     David T. Rubin    
1 Inflammatory Bowel Diseases Center, Humanitas Clinical and Research Center IRCCS and Hunimed,Milan,Italy
2 Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates,Atlanta,United States
3 Nizhni Novgorod Regional Clinical Hospital,Nizhny, Novgorod,Russia
4 Bristol Myers Squibb Company,Princeton,United States

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing